受强制性开放获取政策约束的文章 - Thomas Ahern了解详情
无法在其他位置公开访问的文章：3 篇
Lash et al. respond to “better bias analysis” and “toward better bias analysis”
TL Lash, TP Ahern, LJ Collin, MP Fox, RF MacLehose
American journal of epidemiology 190 (8), 1622-1624, 2021
强制性开放获取政策： US National Institutes of Health
A MicroRNA Approach to Evaluating Elevated Prostate Cancer Risk in Cancer-Free Men
SD Perrapato, NH Farina, AN Berg, HJ Wallace, S Ades, TP Ahern, ...
Critical Reviews™ in Eukaryotic Gene Expression 34, 2024
强制性开放获取政策： US National Institutes of Health
Association of statin use with overall and cancer survival
TP Ahern, S Borgquist, DP Cronin-Fenton
JAMA oncology 4 (7), 1015-1016, 2018
强制性开放获取政策： US National Institutes of Health, Research Council of Norway, Patient …
可在其他位置公开访问的文章：73 篇
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study
TP Ahern, L Pedersen, M Tarp, DP Cronin-Fenton, JP Garne, RA Silliman, ...
Journal of the National Cancer Institute 103 (19), 1461-1468, 2011
强制性开放获取政策： US National Institutes of Health
Statins and breast cancer prognosis: evidence and opportunities
TP Ahern, TL Lash, P Damkier, PM Christiansen, DP Cronin-Fenton
The lancet oncology 15 (10), e461-e468, 2014
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Post-discharge opioid prescribing and use after common surgical procedure
MH Fujii, AC Hodges, RL Russell, K Roensch, B Beynnon, TP Ahern, ...
Journal of the American College of Surgeons 226 (6), 1004-1012, 2018
强制性开放获取政策： US National Institutes of Health
Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study
S Borgquist, A Giobbie-Hurder, TP Ahern, JE Garber, M Colleoni, I Láng, ...
Journal of clinical oncology 35 (11), 1179-1188, 2017
强制性开放获取政策： US National Institutes of Health, Swedish Research Council, Swiss Cancer …
Opioids and breast cancer recurrence: a Danish population‐based cohort study
DP Cronin‐Fenton, U Heide‐Jørgensen, TP Ahern, TL Lash, ...
Cancer 121 (19), 3507-3514, 2015
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study
GV Sørensen, PA Ganz, SW Cole, LA Pedersen, HT Sørensen, ...
Journal of clinical oncology 31 (18), 2265-2272, 2013
强制性开放获取政策： US National Institutes of Health, Danish Council for Technology and …
CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark
TL Lash, D Cronin-Fenton, TP Ahern, CL Rosenberg, KL Lunetta, ...
Journal of the National Cancer Institute 103 (6), 489-500, 2011
强制性开放获取政策： US National Institutes of Health
Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen
TL Lash, D Cronin-Fenton, TP Ahern, CL Rosenberg, KL Lunetta, ...
Acta Oncologica 49 (3), 305-312, 2010
强制性开放获取政策： US National Institutes of Health
Phthalate exposure and breast cancer incidence: a Danish nationwide cohort study
TP Ahern, A Broe, TL Lash, DP Cronin-Fenton, SP Ulrichsen, ...
Journal of Clinical Oncology 37 (21), 1800-1809, 2019
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Statins: a role in breast cancer therapy?
S Borgquist, O Bjarnadottir, S Kimbung, TP Ahern
Journal of internal medicine 284 (4), 346-357, 2018
强制性开放获取政策： US National Institutes of Health, Swedish Research Council
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
TL Lash, L Pedersen, D Cronin-Fenton, TP Ahern, CL Rosenberg, ...
British journal of cancer 99 (4), 616-621, 2008
强制性开放获取政策： US National Institutes of Health
Bias analysis to guide new data collection
TL Lash, TP Ahern
The International Journal of Biostatistics 8 (2), 2, 2012
强制性开放获取政策： US National Institutes of Health
Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors
TP Ahern, TL Lash, SS Thwin, RA Silliman
Medical care 47 (1), 73-79, 2009
强制性开放获取政策： US National Institutes of Health
No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications
TP Ahern, L Pedersen, DP Cronin-Fenton, HT Sørensen, TL Lash
Cancer epidemiology, biomarkers & prevention 18 (9), 2562-2564, 2009
强制性开放获取政策： US National Institutes of Health
Family history of breast cancer, breast density, and breast cancer risk in a US breast cancer screening population
TP Ahern, BL Sprague, MCS Bissell, DL Miglioretti, DSM Buist, ...
Cancer Epidemiology, Biomarkers & Prevention 26 (6), 938-944, 2017
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Use of antipsychotics and risk of breast cancer: a Danish nationwide case–control study
A Pottegård, TL Lash, D Cronin‐Fenton, TP Ahern, P Damkier
British Journal of Clinical Pharmacology 84 (9), 2152-2161, 2018
强制性开放获取政策： Danish Council for Independent Research
Digoxin use and risk of invasive breast cancer: evidence from the Nurses’ Health Study and meta-analysis
TP Ahern, RM Tamimi, BA Rosner, SE Hankinson
Breast cancer research and treatment 144, 427-435, 2014
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定